Osteonecrosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:399158M87
Who is this for?
Show terms as
11Active trials83Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Osteonecrosis, also known as avascular necrosis (AVN), aseptic necrosis, or bone infarction, is a condition where bone tissue dies because it does not get enough blood supply. When blood flow to a section of bone is reduced or cut off, the bone cells begin to die. Over time, this can cause the bone to weaken and eventually collapse, especially near joints. The most commonly affected area is the hip, but osteonecrosis can also occur in the knee, shoulder, ankle, and wrist. Symptoms often start with joint pain that may be mild at first but gradually worsens over weeks or months. In the early stages, you might only feel pain when putting weight on the affected joint. As the condition progresses, pain can occur even at rest, and the joint may become stiff and lose its range of motion. If the bone collapses, the pain can become severe and disabling. Osteonecrosis can be caused by many factors, including long-term use of corticosteroid medications, excessive alcohol use, trauma or fractures, sickle cell disease, and certain autoimmune conditions. In some cases, no clear cause is found, which is called idiopathic osteonecrosis. Treatment depends on the stage of the disease and ranges from medications and physical therapy in early stages to surgical options such as core decompression, bone grafting, or joint replacement in advanced cases. Early detection and treatment are important to preserve the joint and prevent further bone damage.

Also known as:

Key symptoms:

Joint pain that worsens over timePain in the hip, knee, or shoulder areaPain when bearing weight on the affected jointStiffness in the affected jointReduced range of motionLimping or difficulty walkingPain at rest in advanced stagesGroin pain (when the hip is affected)Joint swellingDifficulty with daily activities like climbing stairsSudden onset of severe pain if bone collapsesPain that spreads to the buttock or thigh

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Comparing Implant Retention Versus Removal for MRONJ at Implant Sites

Kyunghee University Dental Hospital — NA

TrialNOT YET RECRUITING
Dec 2025Piezoeletric Surgery vs Conventional Surgery for Treatment of MRONJ

Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA

TrialNOT YET RECRUITING
Sep 2025MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA

TrialNOT YET RECRUITING
Jun 2025The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery

Zhejiang University — PHASE2

TrialNOT YET RECRUITING
Feb 2025Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

The Affiliated Hospital Of Guizhou Medical University — PHASE4

TrialNOT YET RECRUITING
Jan 2025Study of the Clinical and Radiographic Results of a Fixed Polyethylene Posteriorly Stabilized Cemented Total Knee Prosthesis With a Minimum Follow-up of 1 Year.

University Hospital, Strasbourg, France

TrialRECRUITING
Jan 2025Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure

Tanta University — NA

TrialENROLLING BY INVITATION
Dec 2024Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

Huazhong University of Science and Technology — PHASE4

TrialRECRUITING
Oct 2024Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

MoonLake Immunotherapeutics AG — PHASE3

TrialRECRUITING
Oct 2024Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

Mohamed Nasr

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Osteonecrosis.

11 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

11 recruitingView all trials with filters →
Phase 21 trial
Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management
Phase 2
Actively Recruiting
PI: Aurélien LOUVRIER, MD, PhD (CHU de Besançon) · Sites: Besançon; Bordeaux +3 more · Age: 1899 yrs
N/A3 trials
Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
N/A
Actively Recruiting
· Sites: Seoul, GangnamGu · Age: 1999 yrs
Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
N/A
Active
PI: Thomas Bauer, MD, PhD (Hospital Ambroise Paré Paris) · Sites: Bordeaux; Boulogne-Billancourt +5 more · Age: 1874 yrs
Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure
N/A
Enrolling by Invitation
· Sites: Tanta
Other7 trials
Therapeutic Exposures and Risk Factors in MRONJ
Actively Recruiting
PI: Ferit Bayram, PhD (Marmara University Faculty of Dentistry) · Sites: Istanbul · Age: 18110 yrs
Local and Systemic Changes in Osteonecrosis of the Jawbone
Enrolling by Invitation
PI: Stephan Acham (Medical University of Graz) · Sites: Graz · Age: 1899 yrs
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
Actively Recruiting
PI: Rüdiger Zimmerer, PD, MD (University of Leipzig) · Sites: Jacksonville, Florida; Chicago, Illinois +17 more · Age: 1899 yrs
Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction
Actively Recruiting
PI: Johan Abeloos, MD (Department of Oral and Maxillofacial Surgery, Gene) · Sites: Bruges
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
Actively Recruiting
· Sites: Roma · Age: 1899 yrs
Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Actively Recruiting
PI: Johan Abeloos, MD (AZ Sint-Lucas Brugge) · Sites: Antwerp; Antwerp +3 more · Age: 1899 yrs
Immunological Parameters Between MRONJ Stages
Actively Recruiting
PI: Ferit Bayram, PhD (Marmara University Faculty of Dentistry) · Sites: Istanbul · Age: 1880 yrs

Specialists

Showing 25 of 83View all specialists →
TM
Takeshi Sawaguchi, MD
Specialist
PI on 1 active trial
MP
Mariana K Rampazo, PhDCandidate
Specialist
PI on 1 active trial
OP
Olga Di Fede, Professor
Specialist
PI on 2 active trials
PB
Paola Vivoda, BSc
Specialist
PI on 1 active trial
EC
Edward Y Cheng
Specialist
1 Osteonecrosis publication
JH
Jeremy T Hines
WILMINGTON, NC
Specialist
1 Osteonecrosis publication
LJ
Lynne C Jones
Specialist
1 Osteonecrosis publication
TS
Takashi Sakai
Specialist
1 Osteonecrosis publication
TY
Takuaki Yamamoto
Specialist
1 Osteonecrosis publication
SK
Shin Yoon Kim
Specialist
1 Osteonecrosis publication
MM
Michael A Mont
BALTIMORE, MD
Specialist
1 Osteonecrosis publication
HZ
Haiyan Zhao
Specialist
2 Osteonecrosis publications
QC
Quanjun Cui
CHARLOTTESVILLE, VA
Specialist
1 Osteonecrosis publication
KK
Kyung Hoi Koo
ELGIN, IL
Specialist
1 Osteonecrosis publication
YH
Yong Chan Ha
PHILADELPHIA, PA
Specialist
1 Osteonecrosis publication
NS
Nobuhiko Sugano
Specialist
1 Osteonecrosis publication
SG
Stuart B Goodman
Specialist
1 Osteonecrosis publication
WJ
Woo Lam Jo
Specialist
1 Osteonecrosis publication
IM
Irene Lang, MD
FALL RIVER, MA
Specialist
PI on 3 active trials1 Osteonecrosis publication
VG
valerie gangji
Specialist
PI on 1 active trial1 Osteonecrosis publication
TM
Tristan Pascart, MD
Specialist
PI on 3 active trials
HA
Hassan Achakri
Specialist
PI on 13 active trials
AD
Ayse Ayan, Dr
Specialist
PI on 2 active trials
JM
Johan Abeloos, MD
Specialist
PI on 3 active trials
BM
Brendan Stack, MD
SPOKANE VALLEY, WA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Osteonecrosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OsteonecrosisForum →

No community posts yet. Be the first to share your experience with Osteonecrosis.

Start the conversation →

Latest news about Osteonecrosis

Disease timeline:

New recruiting trial: Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: The Effects of General Versus Spinal Anesthesia on Postoperative Myocardial Injury

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Monitoring of the Bone Free Flaps With Microdialysis

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Validation of the O-bridge Protocol: a Prospective, Multicenter Trial

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Immunological Parameters Between MRONJ Stages

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

A new clinical trial is recruiting patients for Osteonecrosis

New recruiting trial: Study of the Clinical and Radiographic Results of a Fixed Polyethylene Posteriorly Stabilized Cemented Total Knee Prosthesis With a Minimum Follow-up of 1 Year.

A new clinical trial is recruiting patients for Osteonecrosis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my osteonecrosis, and what does that mean for my treatment options?,What caused my osteonecrosis, and can we address the underlying cause to prevent it from getting worse?,Am I a candidate for joint-preserving surgery like core decompression, or will I likely need a joint replacement?,Are there medications that could slow down the progression of my bone damage?,How often should I have imaging done to monitor the condition?,What activities should I avoid, and what exercises are safe for me?,Are my other joints at risk for developing osteonecrosis too?

Common questions about Osteonecrosis

What is Osteonecrosis?

Osteonecrosis, also known as avascular necrosis (AVN), aseptic necrosis, or bone infarction, is a condition where bone tissue dies because it does not get enough blood supply. When blood flow to a section of bone is reduced or cut off, the bone cells begin to die. Over time, this can cause the bone to weaken and eventually collapse, especially near joints. The most commonly affected area is the hip, but osteonecrosis can also occur in the knee, shoulder, ankle, and wrist. Symptoms often start with joint pain that may be mild at first but gradually worsens over weeks or months. In the early st

How is Osteonecrosis inherited?

Osteonecrosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Osteonecrosis typically begin?

Typical onset of Osteonecrosis is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Osteonecrosis?

Yes — 11 recruiting clinical trials are currently listed for Osteonecrosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Osteonecrosis?

25 specialists and care centers treating Osteonecrosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.